Gene Security Raises $12M in Series C Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gene Security Networks today said it has closed on a $12 million Series C round of financing, which it will use to bring its gene testing technology to new markets.

Sequoia Capital led the round, which included Claremont Creek Ventures, Founders Fund, and Lightspeed Venture Partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.